This could support the proposed scenario that TRAIL present in the tumor microenvironment, in the absence of plasma membrane expressed anti-apoptotic TRAIL-R4, would enhance TRAIL-R1/-R2-mediated COX2 expression thereby inhibiting γδ T cell activity. This evidence concerns the gene TNFRSF10D and neoplasm.